TARA
Protara Therapeutics Inc
3.40$
-5.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6,896.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -16.4% | -22.4% | +0.0% | +1.2% | -2.4% | +1.2% | +18.1% | -10.2% | +5.7% | -3.2% | -20.0% | – | |
| – | +0.3% | -15.6% | -13.2% | -12.5% | -2.9% | -7.9% | +8.4% | +15.9% | -0.4% | +30.6% | +1.6% | – | |
| – | -112.1% | – | – | +323.6% | +35.1% | -252.8% | – | -111.4% | – | – | – | – | |
| – | -100.0% | – | – | -85.5% | -100.0% | – | -50.0% | -81.8% | +500.0% | -100.0% | – | – | |
| – | +127.6% | +59.1% | -87.3% | -1,098.0% | – | -359.4% | -18.2% | -86.4% | +313.6% | -45.3% | – | – | |
| – | – | – | – | +0.0% | – | – | – | – | – | – | – | – | |
| – | – | -183.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -2,000.0% | – | -100.0% | – | -98.2% | -99.5% | +62.5% | +622,700.0% | -98.6% | -226.0% | – | |
| – | +4,517.5% | +117.3% | +195.4% | -201.3% | – | -164.2% | – | – | – | -194.1% | – | – | |
| – | -6,896.9% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.